Drug intelligence / Profile preview

Tusilin-LS

Development stage
Unknown
Lead developer
Signova
Modality
Small Molecules
Administration
Oral
01

Overview

Tusilin-LS is a combination oral syrup formulated for the treatment of productive (chesty) coughs associated with bronchospasm, which commonly occur in respiratory conditions such as bronchitis and bronchial asthma. Developed by Signova, the formulation contains three active pharmaceutical ingredients: levosalbutamol (a selective beta-2 adrenergic receptor agonist that acts as a bronchodilator to relax airway smooth muscle), ambroxol (a mucolytic agent that thins and loosens thick phlegm), and guaifenesin (an expectorant that increases respiratory tract fluid volume and reduces mucus stickiness). Together, these components work synergistically to clear airway congestion, facilitate expectoration, and ease breathing.

Brand names
Tusilin LSTusilin-LS
Other names
Tusilin LS SyrupTusilin-LS Syrup
02

Targets

SCN10A (Sodium channel protein type X alpha subunit)SCN9A (Sodium channel protein type 9 subunit alpha)ADRB2 (β2)

Beyond the preview

Go deeper on Tusilin-LS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tusilin-LS.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call